NSE BSE
zydus lifesciences ltd stock

ZYDUS LIFESCIENCES LTD Share Price

- - (%)
- NSE: ZYDUSLIFE

ZYDUS LIFESCIENCES LTD Share Price Update

As of the latest trading session, ZYDUS LIFESCIENCES LTD share price is currently at 1141.8, which is down by -43.84 from its previous closing. Today, the stock has fluctuated between 1137.15 and 1170.00. Over the past year, ZYDUS LIFESCIENCES LTD has achieved a return of 96.46 %. In the last month alone, the return has been 9.81 %. Read More...

ZYDUS LIFESCIENCES LTD Performance

Day Range

Low1137.15 High1170.00
1185.65

52 Week Range

Low 567.75 High 1203.00
1185.65

ZYDUS LIFESCIENCES LTD Share Price

7929

532321

ZYDUSLIFE

img img img img
No Data Available

Open Price

1165.00

Prev. Close

1185.65

Volume (Shares)

914361.00

Total traded value

10841.12

Upper Circuit

1304.20

Lower Circuit

1067.10

Note: The current prices & values are delayed, Login to your account for live updates.

ZYDUS LIFESCIENCES LTD Fundamentals


(Standalone)

Market Cap (Cr) 114891.80
PE Ratio (TTM) 34.64
Book Value / Share 156.19
Beta 0.57
ROE 23.45%
EPS (TTM) 34.16
Dividend Yield 0.25%
Net Profit Qtr (Cr) 1405.20

ZYDUS LIFESCIENCES LTD Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars MAR 2024 (Values in Cr)
Revenue 3172.60
Operating Expense 2000.00
Net Profit 1405.20
Net Profit Margin (%) 44.29
Earnings Per Share (EPS) 13.89
EBITDA 1921.70
Effective Tax Rate (%) 16.60
Particulars DEC 2023 (Values in Cr)
Revenue 2225.10
Operating Expense 1903.80
Net Profit 450.40
Net Profit Margin (%) 20.24
Earnings Per Share (EPS) 4.45
EBITDA 805.90
Effective Tax Rate (%) 21.57
Particulars SEP 2023 (Values in Cr)
Revenue 2050.00
Operating Expense 1725.70
Net Profit 805.00
Net Profit Margin (%) 39.26
Earnings Per Share (EPS) 7.96
EBITDA 1183.90
Effective Tax Rate (%) 16.84
Particulars JUN 2023 (Values in Cr)
Revenue 2869.90
Operating Expense 2025.60
Net Profit 780.90
Net Profit Margin (%) 27.21
Earnings Per Share (EPS) 7.71
EBITDA 1223.40
Effective Tax Rate (%) 22.87
Particulars MAR 2023 (Values in Cr)
Revenue 2437.30
Operating Expense 2011.70
Net Profit 490.70
Net Profit Margin (%) 20.13
Earnings Per Share (EPS) 4.85
EBITDA 819.90
Effective Tax Rate (%) 20.21
Particulars MAR 2024 (Values in Cr)
Revenue 10317.60
Operating Expense 7655.09
Net Profit 3441.50
Net Profit Margin (%) 33.35
Earnings Per Share (EPS) 34.01
EBITDA 5134.90
Effective Tax Rate (%) 18.82
Particulars MAR 2023 (Values in Cr)
Revenue 8421.20
Operating Expense 7044.00
Net Profit 1529.20
Net Profit Margin (%) 18.15
Earnings Per Share (EPS) 15.06
EBITDA 2799.00
Effective Tax Rate (%) 24.75
Particulars MAR 2022 (Values in Cr)
Revenue 7590.00
Operating Expense 6532.40
Net Profit 857.90
Net Profit Margin (%) 11.30
Earnings Per Share (EPS) 8.38
EBITDA 1777.50
Effective Tax Rate (%) 26.29
Particulars MAR 2021 (Values in Cr)
Revenue 7436.70
Operating Expense 5993.29
Net Profit 1476.20
Net Profit Margin (%) 19.85
Earnings Per Share (EPS) 14.42
EBITDA 2210.50
Effective Tax Rate (%) 12.57
Particulars MAR 2020 (Values in Cr)
Revenue 5967.70
Operating Expense 5587.09
Net Profit 1412.90
Net Profit Margin (%) 23.67
Earnings Per Share (EPS) 13.80
EBITDA 2220.50
Effective Tax Rate (%) 13.10
Particulars MAR 2024 (Values in Cr)
Book Value / Share 197.11
ROE % 20.64
ROCE % 23.94
Total Debt to Total Equity 0.05
EBITDA Margin 29.04
Particulars MAR 2023 (Values in Cr)
Book Value / Share 173.08
ROE % 14.05
ROCE % 16.25
Total Debt to Total Equity 0.16
EBITDA Margin 23.35
Particulars MAR 2022 (Values in Cr)
Book Value / Share 166.01
ROE % 29.82
ROCE % 14.43
Total Debt to Total Equity 0.29
EBITDA Margin 23.61
Particulars MAR 2021 (Values in Cr)
Book Value / Share 126.88
ROE % 20.32
ROCE % 15.12
Total Debt to Total Equity 0.54
EBITDA Margin 23.86
Particulars MAR 2020 (Values in Cr)
Book Value / Share 101.33
ROE % 14.18
ROCE % 11.91
Total Debt to Total Equity 0.77
EBITDA Margin 20.43
Particulars MAR 2024 (Values in Cr)
Book Value / Share 156.23
ROE % 23.45
ROCE % 22.73
Total Debt to Total Equity 0.37
EBITDA Margin 47.46
Particulars MAR 2023 (Values in Cr)
Book Value / Share 134.78
ROE % 11.38
ROCE % 13.31
Total Debt to Total Equity 0.28
EBITDA Margin 32.06
Particulars MAR 2022 (Values in Cr)
Book Value / Share 129.30
ROE % 8.43
ROCE % 9.84
Total Debt to Total Equity 0.25
EBITDA Margin 26.80
Particulars MAR 2021 (Values in Cr)
Book Value / Share 124.46
ROE % 13.61
ROCE % 12.22
Total Debt to Total Equity 0.32
EBITDA Margin 30.87
Particulars MAR 2020 (Values in Cr)
Book Value / Share 109.96
ROE % 14.25
ROCE % 13.53
Total Debt to Total Equity 0.37
EBITDA Margin 35.92
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 1105.10
Total Assets 29280.80
Total Liabilities 29280.80
Total Equity 22101.60
Share Outstanding 1006233990
Price to Book Ratio 6.43
Return on Assets (%) 13.18
Return on Capital (%) 16.88
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 573.10
Total Assets 25756.40
Total Liabilities 25756.40
Total Equity 19688.30
Share Outstanding 1012204139
Price to Book Ratio 3.65
Return on Assets (%) 7.61
Return on Capital (%) 9.4
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 1106.90
Total Assets 27795.40
Total Liabilities 27795.40
Total Equity 19053.80
Share Outstanding 1023742600
Price to Book Ratio 2.70
Return on Assets (%) 16.14
Return on Capital (%) 19.3
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 888.30
Total Assets 23884.70
Total Liabilities 23884.70
Total Equity 14929.60
Share Outstanding 1023742600
Price to Book Ratio 3.54
Return on Assets (%) 8.93
Return on Capital (%) 10.93
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 964.90
Total Assets 23686.60
Total Liabilities 23686.60
Total Equity 11710.40
Share Outstanding 1023742600
Price to Book Ratio 2.43
Return on Assets (%) 4.96
Return on Capital (%) 6.27
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 414.40
Total Assets 24084.80
Total Liabilities 24084.80
Total Equity 15716.50
Share Outstanding 1006233990
Price to Book Ratio 6.43
Return on Assets (%) 14.28
Return on Capital (%) 15.72
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 248.10
Total Assets 20563.60
Total Liabilities 20563.60
Total Equity 13639.40
Share Outstanding 1012204139
Price to Book Ratio 3.65
Return on Assets (%) 7.43
Return on Capital (%) 8.28
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 302.60
Total Assets 17740.00
Total Liabilities 17740.00
Total Equity 13240.50
Share Outstanding 1023742600
Price to Book Ratio 2.70
Return on Assets (%) 4.83
Return on Capital (%) 5.39
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 154.00
Total Assets 18463.60
Total Liabilities 18463.60
Total Equity 12744.50
Share Outstanding 1023742600
Price to Book Ratio 3.54
Return on Assets (%) 7.99
Return on Capital (%) 8.86
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 385.30
Total Assets 16551.50
Total Liabilities 16551.50
Total Equity 11260.20
Share Outstanding 1023742600
Price to Book Ratio 2.43
Return on Assets (%) 8.53
Return on Capital (%) 9.94
Particulars MAR 2024 (Values in Cr)
Net Income 4838.10
Cash from Operations 4513.70
Cash from Investing -1475.20
Cash from Financing -1810.40
Net change in Cash -57.70
Free Cash Flow 5420.30
Particulars MAR 2023 (Values in Cr)
Net Income 2582.70
Cash from Operations 3280.80
Cash from Investing 1535.00
Cash from Financing -4400.40
Net change in Cash -176.60
Free Cash Flow 4311.70
Particulars MAR 2022 (Values in Cr)
Net Income 5232.30
Cash from Operations 2779.10
Cash from Investing -1000.30
Cash from Financing -868.30
Net change in Cash 235.90
Free Cash Flow 3981.70
Particulars MAR 2021 (Values in Cr)
Net Income 2284.80
Cash from Operations 3638.90
Cash from Investing -724.60
Cash from Financing -2547.70
Net change in Cash 21.60
Free Cash Flow 4492.90
Particulars MAR 2020 (Values in Cr)
Net Income 1495.40
Cash from Operations 3233.60
Cash from Investing -1012.30
Cash from Financing -1528.20
Net change in Cash 391.00
Free Cash Flow 4137.70
Particulars MAR 2024 (Values in Cr)
Net Income 4239.80
Cash from Operations 2896.80
Cash from Investing -1830.60
Cash from Financing -300.80
Net change in Cash -132.30
Free Cash Flow 3481.00
Particulars MAR 2023 (Values in Cr)
Net Income 2032.20
Cash from Operations 1471.40
Cash from Investing -1959.30
Cash from Financing 827.00
Net change in Cash -54.10
Free Cash Flow 2221.50
Particulars MAR 2022 (Values in Cr)
Net Income 1163.90
Cash from Operations 1542.20
Cash from Investing 586.20
Cash from Financing -1709.80
Net change in Cash 148.60
Free Cash Flow 2084.00
Particulars MAR 2021 (Values in Cr)
Net Income 1688.50
Cash from Operations 2491.00
Cash from Investing -2713.80
Cash from Financing 255.30
Net change in Cash -231.30
Free Cash Flow 3019.60
Particulars MAR 2020 (Values in Cr)
Net Income 1625.90
Cash from Operations 1381.80
Cash from Investing 55.00
Cash from Financing -966.70
Net change in Cash 268.90
Free Cash Flow 1978.69
Company Name Price P/E P/B Market Cap 52 Week Low/High
ZYDUS LIFESCIENCES LTD 1184.85 30.89 6.01 119223.63 564.05 / 1203.20
BLISS GVS PHARMA LTD 114.00 12.46 1.23 1194.01 77.65 / 148.95
CIPLA LTD 1511.35 28.66 4.56 122044.23 1020.00 / 1581.70
FERMENTA BIOTECH LIMITED 213.15 0.00 2.16 627.32 136.60 / 219.05
GLAXOSMITHKLINE PHARMA LT 2611.55 67.38 24.88 44241.23 1376.50 / 2759.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
ZYDUS LIFESCIENCES LTD 1184.85 34.69 7.58 119223.63 564.05 / 1203.20
AMRUTAJAN HEALTH LTD 742.65 47.73 7.44 2147.05 556.05 / 826.00
ASTRAZENECA PHARMA IND LT 6566.50 109.81 23.05 16416.25 3715.05 / 7550.00
BLISS GVS PHARMA LTD 114.00 15.68 1.20 1194.01 77.65 / 148.95
ABBOTT INDIA LIMITED 28602.85 50.60 16.43 60781.06 21907.45 / 29628.15

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 1179.00
  • 26 Days 1121.80
  • 10 Days 1158.60
  • 50 Days 1089.50
  • 12 Days 1151.90
  • 100 Days 1035.10
  • 20 Days 1132.90
  • 200 Days 649.00
1186.70
PIVOT
First Resistance 1195.80
Second Resistance 1206.80
Third Resistance 1215.90
First Support 1175.70
Second Support 1166.60
Third Support 1155.60
RSI 79.87
MACD 30.15
Commodity Channel Index (CCI) 103.83
ADX 30.62
Williams % R -11.90

Over 1 Month

down

9.81

Over 3 Months

down

25.39

Over 6 Months

down

67.61

Over 1 Year

down

96.46

Over 3 Years

down

22.54

Over 5 Years

down

37.04

ZYDUS LIFESCIENCES LTD Future

Future: Price

30 May
1003.40
27 Jun
1006.65
25 Jul
1010.20
25 May
0 100 200 300 400 500 600

Discount/Premium

25 Jul
10.50
29 Aug
12.40
25 May
0 1 2 3 4 5 6 7

Active Calls

1000.0
613
1050.0
474
1100.0
423
25 May
0 500 1000 1500 2000 2500 3000

Active Puts

900.0
127
950.0
94
1000.0
87
25 Jul
0 500 1000 1500 2000 2500

ZYDUS LIFESCIENCES LTD Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Others
12.19
Promoter Holdings
74.97
FII
5.58
DII
7.23
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Zydus Family Trust (pankaj R. Patel, Pritiben P. Patel And Sharvil P. Patel-trustees) Shareholding of Promoter and Promoter Group 7.54313343E8 74.96
Llife Insurance Corporation Of India Public Shareholding 3.9121377E7 3.89
Kotak Flexicap Fund Public Shareholding 1.7185064E7 1.71
Icici Prudential Focus Equity Fund Public Shareholding 1.2644115E7 1.26
Taraben Patel Family Will Trust (mr.pankaj R Patel And Dr. Sharvil P Patel-trustees) Shareholding of Promoter and Promoter Group 14775.0 0.0
Pripan Investment Private Limited Shareholding of Promoter and Promoter Group 17730.0 0.0
Shivani Pankajbhai Patel Shareholding of Promoter and Promoter Group 14775.0 0.0
Sharvil Pankajbhai Patel Shareholding of Promoter and Promoter Group 14775.0 0.0
Pritiben Pankajbhai Patel Shareholding of Promoter and Promoter Group 14775.0 0.0
Pankaj Ramanbhai Patel Huf (pankaj Ramanbhai Patel-karta) Shareholding of Promoter and Promoter Group 29550.0 0.0
Pankaj Ramanbhai Patel Shareholding of Promoter and Promoter Group 44326.0 0.0

ZYDUS LIFESCIENCES LTD

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
2023-07-28 6.0 Final 2023-07-28 Equity shares 2022-07-28 2.5 Final 2022-07-29 Equity shares 2021-07-28 3.5 Final 2021-07-30 Equity shares 2020-03-23 3.5 Interim 2020-03-24 Equity shares 2019-07-25 3.5 Final 2019-07-29 Equity shares 2018-07-31 3.5 Final 2018-08-02 Equity shares 2017-03-16 3.2 Interim 2017-03-17 Equity shares 2016-03-17 3.2 Interim 2016-03-18 Equity shares 2015-07-30 12.0 Final 2015-08-03 Equity shares 2014-07-17 9.0 Final 2014-07-21 Equity shares 2013-06-11 7.5 Interim 2013-06-12 Equity shares 2012-07-26 7.5 Final 2012-07-30 Equity shares 2011-07-07 6.25 Final 2011-07-11 Equity shares 2010-07-15 5.0 Final 2010-07-19 Equity shares 2009-07-16 4.5 Final 2009-07-20 Equity shares 2008-07-10 4.5 Final 2008-07-14 Equity shares 2007-07-12 4.0 Final 2007-07-16 Equity shares 2005-07-14 0.0 Final 2005-07-18 Equity shares
Ex-Date Ex-Bonus Ratio
2010-04-06 2010-04-05 1:2 2006-08-31 2006-08-30 1:1
Ex-Date Old FV NEW FV Record Date
2015-10-06 5.0 1.0 2015-10-07

Learn More About Stocks

About ZYDUS LIFESCIENCES LTD

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by ZYDUS LIFESCIENCES LTD

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 5x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Zydus Lifesciences Ltd?

Answer Field

The share price of Zydus Lifesciences Ltd for NSE is ₹ 1141.8 and for BSE is ₹ 1140.8.

What is the Market Cap of Zydus Lifesciences Ltd?

Answer Field

The market cap of Zydus Lifesciences Ltd for NSE is ₹ 1,14,891.80 Cr. and for BSE is ₹ 1,14,791.20 Cr. as of now.

What is the 52 Week High and Low of Zydus Lifesciences Ltd?

Answer Field

The 52 Week High and Low of Zydus Lifesciences Ltd for NSE is ₹ 1203.00 and ₹ 567.75 and for BSE is ₹ 1203.20 and ₹ 564.05.

How to Buy Zydus Lifesciences Ltd share?

Answer Field

You can trade in Zydus Lifesciences Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Zydus Lifesciences Ltd?

Answer Field

The 1 year returns on the stock has been 96.46%.

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

7.5 Lacs+ Users

icon-with-text

4.3+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4300 Cr MTF Book

icon-with-text
loader